Skip to main content
. Author manuscript; available in PMC: 2011 Jun 1.
Published in final edited form as: J Urol. 2010 Jun;183(6):2200–2205. doi: 10.1016/j.juro.2010.02.022

Table 2.

Calculated fracture risks

FRAX fracture risk from clinical risk factors
  including ADT as secondary osteoporosis:
  Median % hip fracture risk (range) 3.1 (0.2–26)
  No. 3% or greater 10-yr hip fracture risk (%) 186 (51.2)
  Median % MOF risk (range) 12 (2.2–33)
  No. 20% or greater 10-y MOF risk (%) 37 (10.2)
FRAX fracture risk from clinical risk factors
  excluding ADT as secondary osteoporosis:
  Median % hip fracture risk (range) 1.8 (0.1–16)
  No. 3% or greater 10-yr hip fracture risk (%) 119 (32.8)
  Median % MOF risk (range) 8.4 (1.6–25)
  No. 20% or greater 10-yr MOF risk (%) 4 (1.1)
FRAX fracture risk calculated using measured
  femoral neck BMD (in 93 pts):
  Median T score (range) −1.0 (−3.4–2.2)
  Median gm/cc BMD (range) 0.81 (0.47–1.23)
  Median % hip fracture risk with DXA (range) 0.9 (0–15)
  Median % hip fracture risk without DXA (range) 2.4 (0.2–26)
  Median % MOF risk with DXA (range) 7.0 (2.5–25)
  Median % MOF risk without DXA (range) 11 (3.0–33)
  No. 3% or greater 10-yr hip fracture risk + T
    score less than −1 (%)
14 (15)
  No. 3% or greater 10-yr hip fracture risk without
    DXA (%)
41 (44.1)
  No. T score −2.5 or less (%) 6 (6.5)